3Petersein J,Spinazzi A ,Giovagnoni A,et al. Focal liver lesions; evalu- ation of the efficacy of gadobenate dimeglumine in MR imaging a mul- ticenter phase III clinical study [ J ]. Radiology,2000,215 (3) :727.
4Bell JD, Bhakoo KK. Metabolic changes underlying 31P MR spectral alterations in human hepatic tumours (Review) [ J ]. NMR Biomed, 1998, 11(7) :354-359.
5Kuo YT, Li CW, Chen CY, et al. In vivo proton magnetic resonance spectroscopy of large focal hepatic lesions and metabolite change of hepatoceUular carcinoma before and after transcatheter arterial chemo- embolization using 3.0-T MR scanner [ J ]. J Magn Reson Imaging, 2004, 19(5) :598-604.
6Kopka L, Rodenwaldt J, Hamm BK. Biphasic multi-slice helical CT of the liver: Intraindividual comparison of different slice thicknesses for the detection and characterization of focal liver lesions [ J ]. Radi- ology, 2000, 217(2) :367-368.
8Oliver JH, Baron RL, Federle MP, et al. Detecting hepatocellular carcinoma: value of unenhanced or arterial phase CT imaging or both used in conjunction with conventional portal venous phase contrast-en- hanced CT imaging[J]. AJR, 1996, 167(1) :71-77.
10Talbot JN,Fartoux L,Balogova S,et al. Detection of hepa-tocellular carcinoma with PET/CT:A prospective comparison of 18F -fluorocholine and 18F-FDG in patients withcirrhosis or chronic liver disease[J], J Nucl Med,2010,51(11):1699-1706.
